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Zebrafish as a new model to study 
effects of periodontal pathogens on 
cardiovascular diseases
Magdalena Widziolek1, Tomasz K. Prajsnar2,3,†, Simon Tazzyman4, Graham P. Stafford5, 
Jan Potempa1,6 & Craig Murdoch5
Porphyromonas gingivalis (Pg) is a keystone pathogen in the aetiology of chronic periodontitis. 
However, recent evidence suggests that the bacterium is also able to enter the bloodstream, interact 
with host cells and tissues, and ultimately contribute to the pathogenesis of cardiovascular disease 
(CVD). Here we established a novel zebrafish larvae systemic infection model showing that Pg rapidly 
adheres to and penetrates the zebrafish vascular endothelium causing a dose- and time-dependent 
mortality with associated development of pericardial oedemas and cardiac damage. The in vivo model 
was then used to probe the role of Pg expressed gingipain proteases using systemically delivered 
gingipain-deficient Pg mutants, which displayed significantly reduced zebrafish morbidity and mortality 
compared to wild-type bacteria. In addition, we used the zebrafish model to show efficacy of a gingipain 
inhibitor (KYT) on Pg-mediated systemic disease, suggesting its potential use therapeutically. Our 
data reveal the first real-time in vivo evidence of intracellular Pg within the endothelium of an infection 
model and establishes that gingipains are crucially linked to systemic disease and potentially contribute 
to CVD.
Porphyromonas gingivalis (Pg) is a Gram-negative anaerobe considered a keystone pathogen in the development 
of severe periodontitis1; a chronic inflammatory disease of the gingiva and tooth supporting structures that, 
if untreated, leads to tooth loss due to bone resorption and destruction of surrounding soft tissues2. Pg pro-
duces several virulence factors that enable the microbe to colonize the host and evade the immune system3. The 
most predominant of these virulence factors are cysteine proteases termed gingipains that are responsible for 
the majority of the bacterial proteolytic activity4. Gingipains consist of the arginine-specific (RgpA, RgpB) and 
lysine-specific (Kgp) endopeptidases encoded by rgpA, rgpB and kgp genes respectively. As well as degrading host 
proteins to provide nutrients for growth, gingipain activity is also crucial for bacterial adhesion, invasion, host cell 
death and subversion of the host immune response (reviewed by Guo et al. and Hajishengallis)5,6.
Studies show that Pg frequently enters the bloodstream at oral sites through bleeding with tooth brushing or 
during dental procedures causing a transient bacteremia7. Considering the growing number of reports of Pg sys-
temic dissemination, it is not surprising that periodontitis has been shown to affect the general health status and 
there is increasing evidence of its association with systemic inflammation6 as well as systemic conditions such as 
cardiovascular disease8, atherosclerosis9,10 and diabetes11. However, to date, little is known about how Pg interacts 
with the vasculature and which virulence factors are important for systemic pathogenesis.
Murine models have been predominantly used to study Pg pathogenicity, either in the oral cavity12 or system-
ically13,14. However, these models are expensive and provide limited data on molecular mechanism, so recently 
other in vivo systems have been developed using lower order organisms. Zebrafish (Danio rerio) have been used 
as an alternative model to study human diseases as they provide physiological and anatomical systems similar to 
higher organisms but remain affordable. They are easier to genetically manipulate and so generation of knock-out 
mutants or fluorescently-tagged cell types is more accessible15,16. Recently, zebrafish larvae have been used as 
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a model system to study human infectious diseases and virulence of bacterial pathogens such as Enterococcus 
faecalis17, Salmonella typhimurium18, Psudomonas aeruginosa19 and Staphylococcus aureus20. One of the main 
advantages for using zebrafish to study infectious diseases is the possibility of non-invasive real-time imaging 
in vivo at the cellular level. Since larval zebrafish are transparent the fate of fluorescently-labelled bacteria after 
injection into zebrafish larvae can be monitored and their co-localization with fluorescently-tagged host cells 
examined, making these models an attractive alternative to other vertebrate systems where disease development 
cannot be visualized17,21.
In this study we used a zebrafish larvae infection model to study the mechanisms of Pg systemic pathogenicity. 
Using gingipain knock-out mutants and protease inhibitors we identify, for the first time, the crucial role that 
these proteases play during systemic infection, and show the ability of these bacteria to cross the vasculature and 
disseminate into surrounding tissues in vivo. Data presented here demonstrate that the zebrafish model is suitable 
to study both the host response to Pg infection as well as bacterial virulence and provides a powerful optically and 
genetically accessible tool to study the systemic pathogenicity of oral bacteria.
Results
P. gingivalis is pathogenic for zebrafish larvae in a systemic infection model. To determine 
whether Pg W83 strain is virulent in a systemic infection model, zebrafish larvae were injected at 30 hours 
post-fertilization (hpf) and survival monitored up to 72 hours post-infection (hpi). We observed a dose- and 
temperature-dependent increase in mortality that was significantly (p < 0.05) different to PBS-injected controls 
at 48 and 72 hpi (Fig. 1a,b). A LD50 was established when 5 × 104 CFU Pg W83 were injected into zebrafish for 
48 hpi at 30 °C and so these conditions were used throughout the remainder of the study. We noted that zebrafish, 
remaining viable after infection with W83, presented with visible signs of systemic disease that increased with 
severity overtime compared to controls. In particular, zebrafish displayed severe pericardial and yolk sac oedemas 
as early as 24 hpi along with eye abnormalities and lordtic spine curving (Fig. 1c,d). In addition, W83-infected 
embryos developed marked cardiac injury as early as 24 hpi. The atrium and ventricle were separated forming 
thin, elongated chambers within an oedemic appendage and the cardiac tissue displayed extensive damage upon 
Figure 1. Systemic infection of zebrafish larvae with Pg W83 leads to fish mortality and morbidity in a 
dose- and temperature-dependent manner. Kaplan-Meier survival plots of zebrafish larvae infected with 
increasing doses of Pg W83 strain at 30 °C (a) or temperature-dependent survival of zebrafish larvae infected 
with 4 × 104 CFU W83 strain (b). At least three individual experiments were performed (n ≥ 20 larvae per 
group in each experiment). Comparisons between survival curves were made using the log rank test. Levels 
of dead, oedematous or healthy Pg W83-infected larvae for up to 72 h upon injection with 5 × 104 CFU Pg 
W83 (c). Development of the oedema disease phenotype in zebrafish larvae infected with Pg W83 or PBS-
injected controls over 72 h. Black arrows indicate pericardiac and yolk sac oedemas, red arrows indicate eye 
abnormalities and blue arrowhead indicates spine curving in W83-infected larvae. At least three individual 
experiments were performed (n ≥ 20 larvae per group in each experiment). Scale bars = 500 in (d).
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histological analysis (Fig. 2a). Further tissue damage was apparent within the yolk sac and cranial regions that 
displayed evidence of tissue necrosis (Fig. 2b).
P. gingivalis W83 disseminates rapidly in zebrafish larvae, infecting endothelial cells and crossing 
the vasculature to invade surrounding tissues. We next performed real-time, confocal in vivo imaging 
of kdrl:memRFP transgenic zebrafish embryos (red-labelled endothelial cells) infected systemically with fluo-
rescently labelled Pg W83 to determine its cellular targets and if the bacterium could traverse the endothelium. 
Pg was disseminated rapidly in zebrafish and was found associated and co-localised with the inter-segmental 
endothelial cells at 1 hpi (Fig. 3) providing evidence of adhesion to the endothelium and intracellular locali-
zation in vivo. In addition, Pg was observed outside the red-labelled endothelial cells indicating that bacteria 
had bound to and crossed the vasculature before entering into the surrounding tissue (Fig. 3C). As well as the 
inter-segmental vessels we observed Pg localization in other highly vascularized tissues including the eye, tail and 
yolk sac at 1 and 24 hpi (Supplementary Fig. 1). We also observed strong Pg adhesion to cardiac tissues where 
bacteria were not dislodged from tissue despite the intracardiac blood flow (Fig. 3D and Supplementary Movie 1). 
To visualize the innate immune response to the systemic infection we dual-labelled Pg with the pH sensitive dye, 
pHrodo (non-fluorescent until it is acidified within phagosomes where upon it fluoresces red) and fluorescein 
to visualize phagocytosed bacteria. After 1 hpi phagocytes had bound and ingested Pg and many bacteria were 
localized within phagosomes (Fig. 3E). Phagocytosis was observed in all tissues examined at this time point and 
was increased at 24 hpi which was associated with a concurrent decrease in bacterial load (Supplementary Fig. 1).
W83 is the most virulent strain of P. gingivalis in the zebrafish larvae infection model. Previous 
studies have shown that strains of Pg isolated from patients with periodontitis exhibit different levels of path-
ogenicity in both in vitro and in vivo models22,23. We selected three extensively studied strains of Pg (W83, 
ATCC 33277 and FDC 381) and compared their virulence in the zebrafish larvae systemic infection model. 
Kaplan-Meier plots show that strain W83 was the most virulent in terms of mortality causing significantly more 
death (p < 0.01) than ATCC33277 and FDC 381 by 72 hpi (Fig. 4a). In contrast, the virulence of ATCC33277 and 
381 were not significantly different from each other, causing less than 20% mortality of infected larvae by 72 hpi 
(Fig. 4a). This inter-strain variability was also observed for the development of disease symptoms in infected 
embryos where infection with W83 rapidly led to oedemas in the vast majority of infected larvae at 24 hpi with 
an associated mortality rate of more than 50% of larvae by 72 hpi (Fig. 4b–d). Similarly, 80 ± 14% of ATCC33277 
infected larvae had developed oedemas at 24 hpi but the effect appeared to be less progressive than for W83 as 
only 16 ± 9% of larvae were killed by 72 hpi (Fig. 4b–d). Pg strain FDC 381 was the least virulent in terms of 
inducing both systemic disease and mortality. Indeed, some of the larvae displaying oedema were able to recover 
from this condition by 72 hpi (Fig 4b–d).
Mortality of P. gingivalis-infected zebrafish larvae depends on the viability of the pathogen 
and its active cell surface components. To determine if microbial viability was essential for virulence, 
zebrafish larvae were injected with viable, heat-killed (HK) or formalin-fixed (FF) Pg W83 and mortality assessed. 
Kaplan-Meier analysis showed that HK or FF treatment of Pg markedly attenuated bacterial virulence causing a 
significant reduction (p < 0.0001) in zebrafish mortality after 72 hpi when compared to zebrafish injected with 
viable Pg (Fig. 5a). Although there was no difference in the percentage of zebrafish larvae killed with the different 
treatments after 24 h, more (88 ± 8%) zebrafish displayed oedemas compared to 42 ± 9% for FF and only 13 ± 5% 
Figure 2. Effect of wild-type Pg W83 on zebrafish larvae tissue structure. Lateral view of impaired, elongated 
heart morphology of Pg W83-infected larvae; white arrowhead indicates heart. Heart chambers were distant 
and much smaller in comparison to PBS-injected control larvae (a). Sagittal histological sections of H&E 
stained 48 hpi Pg W83-infected larvae revealing advanced tissue damage in the cranial and cardiac regions 
along with yolk sac oedemas (b). In all figures larvae were infected with 5 × 104 CFU Pg at 30 hpf W83 or PBS as 
a control. At least three individual experiments were performed and images are representative of at least n = 5 
larvae per group in each experiment. Scale bars = 100 μ m in (a) and 200 μ m in (b).
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for HK Pg (Fig. 5b). In zebrafish larvae injected with viable bacteria, almost all fish developed progressive disease 
symptoms that eventually led to the death of 56 ± 5% of larvae by 72 hpi (Fig. 5c,d). In contrast, the majority of the 
HK-infected embryos remained disease-free over a 72 h period (p ≤ 0.05, Fig. 5b–d) with only a minority experi-
encing oedema or mortality. A similar effect was observed for FF Pg-infected larvae although this group displayed 
consistently more oedema than the HK Pg-treated group over a 72 h period (Fig. 5b–d). As well as ensuring loss of 
viability heat treatment and fixation may also affect the activity of virulence factors, in particular those associated 
with enzyme activity. We found that treatment with elevated temperatures of 60 °C almost abolished the activity 
of both lysine (Kgp) and arginine (RgpA and RgpB) specific gingipains, whereas fixation of bacteria with 10% 
Figure 3. Pg W83 disseminates rapidly in zebrafish larvae and is able to cross the vascular barrier to 
invade surrounding tissues. Confocal images of kdrl:memRFP transgenic zebrafish larvae at 1 hpi following 
systemic infection with PBS control (a) or fluorescein-labelled 5 × 104 CFU Pg W83 (b,c). Fluorescent Pg W83 
was co-localised to the red-labelled endothelium (white arrowhead in c) and cross the vasculature into the 
tissue (blue arrowheads in c). Light sheet image of fluorescein-labelled Pg W83 adherent to the heat tissues of 
zebrafish larvae (d). Pg are rapidly phagocytosed; high-power image of phagocytosed Pg within a phagocyte 
(red, black arrowhead) and non-phagocytosed Pg (green, orange arrowhead) (e). Scale bar = 20 μ m. Images are 
representative of two independent experiments showing similar findings.
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formalin reduced the activity of these gingipains by 60% (lysine specific) and 90% (arginine specific) respectively 
(Supplementary Fig. 2) indicating that these proteins may be important in mediating virulence.
Gingipains are crucial virulence factors of P. gingivalis in zebrafish systemic disease. To exam-
ine whether gingipains play a role systemic disease, zebrafish larvae were infected with wild-type (WT) parental 
strain W83, single (Δ Kgp, Δ RgpA or Δ RgpB), double (Δ K/Ra) or triple (Δ K/Ra-b) gingipain-deficient mutants. 
Removal of any of the gingipains caused an increase in the survival rate of infected larvae compared to WT W83 
and this effect was additive with respect to the double or triple mutants whose mortality rates were similar to PBS 
controls (p ≤ 0.01 for Δ K/Ra and p ≤ 0.0001 for Δ K/Ra-b; Fig. 6a). With the exception of the Δ K/Ra-b triple 
mutant, zebrafish larvae injected with any of the mutated strains of Pg caused significant oedema in the first 24 hpi 
although there was little mortality (Fig. 6b). By 48 and 72 hpi (Fig. 6c) the levels of oedema remained the same; 
however, larvae mortality was increased to 60% for WT W83 Pg and 40% for lysine-deficient mutant (Δ Kgp). 
Levels of larvae mortality were slightly, but not significantly, reduced upon infection with the arginine-deficient 
mutants Δ RgpA and Δ RgpB compared to Δ Kgp. The Δ K/Ra-deficient mutant produced mortality levels of 
~10% after 72 hpi whilst gingipain triple mutants (Δ K/Ra-b) were virtually avirulent, producing a larvae pheno-
type similar to PBS controls (Fig. 6c,d).
To confirm these findings we used a specific inhibitor of arginine and lysine gingipains (KYT)24 on W83 Pg to 
directly inhibit the proteolytic activity before systemic injection. The amount of inhibitor required to completely 
inhibit gingipain activity was determined in vitro before use in vivo (data not shown). We found that infection 
with W83 + KYT significantly (p < 0.001) reduced larvae mortality by 48 and 72 hpi compared to those injected 
without inhibitor (Fig. 7a–c). However, the presence of gingipain inhibitor did not influence the number of larvae 
displaying signs of oedema compared to WT-infected Pg over a 72 h period (Fig. 7a–c).
Figure 4. Virulence of Pg is strain-specific in the zebrafish larvae infection model. Kaplan-Meier survival 
plots of zebrafish larvae infected with 1.6 × 104 CFU of W83, ATCC33277 or FDC 381 strains (a). Percentage 
of dead, oedematous or healthy Pg W83, ATCC33277 or FDC 381-infected larvae after 24, 48 and 72 hpi 
respectively (b–d). Larvae were injected with different strains of Pg at 1.6 × 104 CFU. At least three independent 
experiments were performed (n ≥ 20 larvae per group in each experiment). **p ≤ 0.01, ***p ≤ 0.001. 
Comparisons between survival curves were made using the log rank test. Differences between groups displaying 
oedema were measured using One-way ANOVA after normality was assured.
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Discussion
There is increasing evidence to suggest that Pg influences the progression of chronic systemic conditions such as 
cardiovascular disease25,26. In support of this Pg has been found in atherosclerotic plaques27,28 and has been found 
to influence myocardial infarction in a murine model29. In this study we used zebrafish larvae, an in vivo model 
system that has been successfully used to investigate host-pathogen interactions30 to examine the effects of Pg on 
the circulatory system. We used a well-established systemic infection route20,31 along with genetically engineered 
zebrafish larvae that allowed us to examine, for the first time, the interaction of Pg with the vasculature at the 
cellular level in vivo.
We found that systemic infection with W83, a highly virulent strain of Pg compared to other strains tested, 
lead to dose-dependent disease severity and mortality in larvae32,33. A similar dose-dependent disease effect has 
been previously observed using a Drosophila melanogaster infection model albeit via a non-systemic route34. In 
addition, we observed extensive damage to the heart and surrounding tissue associated with pericardial oedemas. 
Microbial-mediated pericarditis in humans often leads to pericardial oedema and DNA from Pg along with that 
from other oral bacteria have been isolated from pericardial fluid and in endocarditis lesions35 suggesting that, 
although exaggerated, the disease process in zebrafish may reflect those in humans.
Using real-time in vivo confocal imaging we observed Pg both closely associated to and within endothelial 
cells of the vasculature, confirming in vitro data that Pg can adhere and be internalized by endothelial cells36. In 
addition, we found Pg deep within tissues showing that once internalized Pg are able to survive within endothelial 
cells and be released into tissues in vivo37,38. Li et al. showed in vitro that Pg can be transmitted intracellularly from 
cell to cell as a mechanism of spreading within the endothelium, and that these bacteria were able to replicate 
once within newly infected cells and then be released for further uptake39. Although we could recover viable Pg 
from infected zebrafish, we were are unable to determine if the bacterium replicated in vivo and so further studies 
are required to resolve this issue.
Although innate immune cells rapidly internalized and phagocytosed bacteria we also observed marked num-
bers of Pg in the circulatory system that was associated with significant damage and oedema in several tissues, 
most noticeably the pericardium and yolk sac. Moreover, this pathology was dependent upon the presence of 
gingipain proteases as lysine and arginine gingipain-deficient strains were both significantly less virulent, sug-
gesting both types of gingipains can mediate tissue damage. Indeed, gingipain-null (Δ K/Ra-b)-infected zebrafish 
displayed no disease symptoms.
Figure 5. Heat and formalin treatment of Pg W83 decreases its pathogenicity in vivo. Kaplan-Meier survival 
plots of zebrafish larvae infected with viable, heat-killed (HK) or formalin-fixed (FF) Pg W83 (a). Percentage 
of dead, oedematous or healthy Pg W83-infected larvae after 24, 48 and 72 hpi respectively (b–d). Larvae were 
injected with viable, 60 °C HK or 10% FF Pg W83 at 5 × 104 CFU. At least three individual experiments were 
performed (n ≥ 20 larvae per group in each experiment). ***p ≤ 0.001. Comparisons between survival curves 
were made using the log rank test. Differences between groups displaying oedema were measured using One-
way ANOVA after normality was assured.
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The importance of gingipains in causing periodontal as well as vascular damage in murine models has been 
previously highlighted40,41 and more recently gingipains were found to mediate myocardium damage in a murine 
model of Pg-aggravated myocardial infarction29. Several elegant studies have shown that either the lysine or 
arginine-specific gingipains mediate tissue damage by cleaving and therefore inactivating many important host 
extracellular matrix molecules including laminin, fibronectin and collagen, leading to loss of cell-matrix con-
tacts that are crucial for tissue integrity and cell survival42. Moreover, this tissue destruction is exacerbated by 
Pg-mediated activation of matrix metalloproteinases, in particular MMP343 and MMP944. As well as disrupting 
cell-matrix interactions, there is in vitro evidence that gingipains also disturb endothelial cell-to-cell contacts. 
Sheets et al. found that lysine and arginine gingipains cleaved N- and VE-cadherin as well as integrin β 1 expressed 
by monolayers of human microvascular endothelial cells leading to cell detachment along with caspase-mediated 
and caspase-independent apoptosis45,46. Given this data it is plausible that the increased vascular permeability 
leading to oedema we observed in systemically infected zebrafish may be due to gingipain-mediated damage of 
adhesion molecules leading to loss of endothelial adherin, gap and tight junction integrity. This may be further 
aggravated by reduced endothelial contacts with underlying connective tissue or support cells in more mature 
vessels. The model established here will pave the way for further studies to measure the effect of Pg and its viru-
lence determinants on vascular leakage using a range of zebrafish lines open to the field.
Recently, small peptide analogs (KYT-1 and KYT-36) that are selective inhibitors of Kgp and Rgp, respec-
tively47,48 have been developed. These inhibitors have been shown to suppress the pathogenic potential of Pg in 
murine models24. Similarly, we found that zebrafish systemically infected with WT Pg W83 along with KYT1 and 
KYT36 displayed significantly reduced mortality and disease symptoms, suggesting not only that these inhibitory 
molecules show therapeutic promise but that the zebrafish infection model may be used to screen other therapeu-
tic agents and strategies aimed at Pg or other bacterial-mediated systemic diseases.
Figure 6. Gingipains are crucial virulence factors of Pg in the zebrafish larvae infection model. Kaplan-
Meier survival plots of zebrafish larvae infected with Pg W83 (WT), Δ RgpA deficient mutant, Δ RgpB deficient 
mutant, Δ Kgp deficient mutant, Kgp and RgpA deficient mutant (Δ K/Ra) or gingipain null mutant (Δ K/Ra-b) 
(a). Percentage of dead, oedematous or healthy WT Pg W83 or gingipain mutant-infected larvae after 24  
(b) and 72 hpi (c) respectively. Morphology of zebrafish larvae 72 hpi with WT or Δ K/Ra-b mutant of Pg W83 
(d). PBS was injected as a control. All experiments were performed at least 3 times. Bars represent means ± SD. 
In all experiments WT Pg or its gingipain mutants were injected into 30 hpf zebrafish larvae at 5 × 104 CFU. 
Black arrow indicates oedemas in WT Pg W83-infected larvae. Scale bar = 500 μ m. Comparisons between 
survival curves were made using the log rank test. Differences between groups displaying oedema were 
measured using One-way ANOVA after normality was assured.
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In summary, this study reveals that zebrafish larvae represent a powerful novel vertebrate model system 
to examine the role of Pg and potentially other periodontal bacteria in cardiovascular disease or endocarditis. 
Additionally, we demonstrated for the first time that Pg gingipains are crucially important in mediating systemic 
disease. We believe that this in vivo model system will provide an amenable tool to further examine the mecha-
nism of Pg-mediated systemic disease at the cellular and molecular level.
Methods
Bacteria, zebrafish strains and culture conditions. All strains of Pg and Danio rerio used in this study 
are listed in Table 1. Wild-type Pg W83 strain and its isogenic mutants were maintained on Schaedler (BTL 
Spolka, Poland) anaerobe blood agar (ABA) plates supplemented with 0.5 mg/L menadione sodium bisulfate, 
0.25 g/L L-cysteine-HCl, 5 mg/L hemin, 5% (v/v) defibrinated horse blood and antibiotic (1 μ g/ml tetracycline 
or 5 μ g/ml erythromycin) when appropriate. For liquid cultures, strains were grown in hemin, menadione and 
L-cysteine supplemented Schaedler broth. ATCC33277 and FDC 381 strains were maintained on fastidious 
anaerobe agar (Lab M, Bury, UK) supplemented with 5% (v/v) oxylated horse blood (Oxoid, Basingstoke, UK). 
For growth in liquid cultures these strains were grown in brain-heart infusion broth (BHI; Oxoid) supplemented 
with 5 g/L yeast extract (Oxoid), 5 mg/L hemin and 0.5 mg/L menadione. Agar plates or liquid cultures were 
incubated at 37 °C in an anaerobic chamber (80% N2, 10% CO2 and 10% H2). For experiments, strains were 
grown in broth overnight at 37 °C in anaerobic conditions after which fresh cultures were set to an optical density 
(OD600) equal to 0.1 and cultured until late log phase. Bacteria were harvested by centrifugation at 6,000 × g for 
10 min, washed with PBS and resuspended at 5 × 109 CFU/ml. For formalin fixation, Pg was resuspended in 10% 
PBS-buffered formalin and incubated overnight at 4 °C. For heat killing, bacteria were resuspended in PBS and 
incubated in a water bath at 60 °C for 30 min. The loss of bacterial viability was confirmed by culture on ABA 
plates. For inhibition of gingipain activity, Pg (OD600 = 1.0) were pretreated with KYT-1 or KYT-36 inhibitors24 
at a final concentration of 2 μ M and bacteria were incubated for 30 min at 37 °C in anaerobic conditions; after 
which, bacteria were washed once with PBS, resuspended at 5 × 109 CFU/ml and injected into zebrafish larvae. 
Figure 7. Effect of gingipain inhibitor KYT on zebrafish larvae mortality and morbidity. Percentage of 
dead, oedematous or healthy zebrafish larvae infected with 5 × 104 CFU Pg W83 at 30 hpf in the absence or 
presence of KYT inhibitor after 24 (a), 48 (b) and 72 hpi (c) respectively. PBS was injected as a control. At least 
three individual experiments were performed and bars represent means ± SD. Differences between groups 
displaying oedema were measured using One-way ANOVA after normality was assured.
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Zebrafish maintenance and experimental work was performed in accordance with UK Home Office regulations 
and UK Animals (Scientific Procedures) Act 1986. Ethical approval was given by the University of Sheffield Local 
Ethical Review Panel. London wild-type (LWT) inbred zebrafish larvae were obtained from The Bateson Centre, 
University of Sheffield. The transgenic kdrl:memRFP strain was used to enable visualization of the endothelium as 
previously described. All larvae were maintained in E3 medium at 28.5 or 30 °C according to standard protocols 
and monitored for up to 4 days post-fertilization (dfp).
Microinjection of P. gingivalis onto zebrafish embryos. Pg were injected systemically by direct inoc-
ulation into the common cardinal vein (Duct of Cuvier) of dechorionated larvae at 30 hpf as previously described 
with PBS used as control20. Briefly, tricaine-anesthetized larvae were embedded and positioned in a solution of 
3% (w/v) methylcellulose (Sigma Aldrich) in E3 medium on glass slides. Larvae were injected individually using 
micro-capillary needles loaded with known concentrations of Pg and were monitored for disease development 
and survival for up to 72 hpi unless otherwise stated. Zebrafish viability was assessed by examining the presence 
of a heart beat and blood flow within the circulation. Live imaging of anesthetized zebrafish larvae was performed 
using spinning disc confocal microscopy (Perkin Elmer). At least 20 zebrafish were injected per treatment group 
in all experiments.
Evaluation of gingipain activity. To evaluate gingipain proteolytic activity Pg cultures were adjusted to 
OD600 1.0. Ten microliters (for Rgp) and 20 μ L (for Kgp) of bacterial suspension were pre-activated in TNCT 
activity buffer (50 mM Tris-HCl pH 7.5, 5 mM CaCl2, 150 mM NaCl, 0.05% Tween-20 supplemented with 10 mM 
L-cysteine-HCl neutralized with 10 mM NaOH) for 5 minutes at room temperature in a total volume of 200 μ L 
in a 96-well plate. Substrate (0.4 μ L, final concentration 200 mM) was added and the rate of its hydrolysis was 
recorded at 405 nm using a spectrophotometer as described previously49. N-(p-Tosyl)-Gly-Pro-Lys-p-nitroanilide 
and benzoyl-arginine-p-nitroanilide (BApNA) (both from Sigma Aldrich) were used as substrates specific for 
Rgps and Kgp, respectively.
Histological processing of zebrafish. Infected and control zebrafish were fixed in 10% PBS-buffered for-
malin for at least 24 h and then paraffin wax-embedded. Tissue sections (5 μ m) were cut, dewaxed in xylene, rehy-
drated through a series of alcohols to water and stained with haematoxylin and eosin (H&E). Sections of zebrafish 
were then dehydrated, mounted in DPX and images taken using an Olympus BX51 microscope and a IIIu camera 
with associated Cell^D software (Olympus, GmbH, Münster, Germany).
Labeling of P. gingivalis and fluorescence microscopy. To visualize bacteria and to monitor phago-
cytosis in vivo, Pg were fluorescently labeled with fluorescein-5-EX and/or pHrodo red succinimidyl ester (Life 
Technologies, Paisley, UK) respectively. Prior to injection, a 200 μ L bacterial suspension of Pg (in PBS; pH 9) was 
simultaneously mixed with 0.25 μ L fluorescein-5-EX (10 mg/ml) and/or 0.25 μ L of pHrodo red (1.7 mg/ml) for 
30 min at 37 °C in the dark with shaking (100 rpm). Bacteria were washed twice with PBS (pH 8) to remove excess 
dye, resuspended in PBS (pH 7.4) to an OD600 5.0 (~5 × 109 CFU/ml) and 2 nL injected into each zebrafish. At 
2 hpi, six infected larvae were anesthetized, mounted in 1% low-melting-point agarose in E3 medium on covers-
lips. Fluorescent bacteria were visualized using either a spinning disc laser scanning confocal microscope (Perkin 
Elmer) and images acquired and processed using Volocity software (Improvision, Perkin Elmer) or a Zeiss Z1 
light-sheet microscope with Zen Black 2014 software.
Data and statistical analysis. All data presented is from at least 3 independent experiments with results 
expressed as the mean ± SD. Survival data were evaluated using the Kaplan-Meier method and comparisons 
between individual curves were made using the log rank test. Differences between groups displaying oedema 
were measured using One-way ANOVA after normality was assured. All analysis was performed using Graphpad 
Prism v6.0 (GraphPad, La Jolla, CA) and statistical significance was assumed if p < 0.05.
Strains Genotype/Description Reference
P. gingivalis
 W83 Wild-type Reference strain50
 Δ K/Ra-b kgp∆598-1732::Tcr rgpA-::Cmr rgpB∆410-507::Emr 51
 Δ RgpA rgpB + ::Emr rgpA-::Cmr 52
 Δ Kgp kgp∆598-1732::Tcr 53
 Δ K/Ra kgp∆598-1732::Tcr rgpA-::Cmr 54
 Δ RgpB rgpB∆410-507::Emr 52
 FDC 381 Wild-type Forsyth Dental Center, Boston, MA
 ATCC33277 Wild-type 55
Zebrafish
Tg(kdrl:memRFP) 56
Table 1.  P. gingivalis, zebrafish strains and bacterial culture conditions used in this study.
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Supplementary	Figure	1	
SF. 1. Confocal images of zebrafish larvae at 1 and 24 hpi following systemic infection with 5 x 104 
CFU fluorescein and pHrodo labelled Pg W83. Small green dots represent non-phagocytosed Pg 
whilst small red dots are phagocytosed Pg. The large red staining in the PBS controls in the tail 
image is due to increased pigmentation along the back of the larvae at this stage or larvae 
development. Similar pigmentation was observed in the eye at 24 hpi masking the presence of Pg in 
this tissue and so this data is not shown. Images show the presence of less Pg in the tissues at 24 hpi 
with increased levels of phagocytosis. W83 Pg were injected into 30 hpf zebrafish larvae at 5 x 104 
CFU in each experiment.  Scale bar = 50µm. 
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SF.2	Kgp	and	Rgp	acKvity	in	cultures	of	viable,	heat-killed	(HK)	and	formalin-
ﬁxed	(FF)	wild-type	Pg	W83.	The	acKvity	of	HK	or	FF	Pg	W83	was	calculated	
as	the	percentage	of	the	acKvity	of	viable	bacteria.	
Supplementary	Fig.	2	
Supplementary	Video:	Light	sheet	real-Kme	move	of	ﬂuorescein-labelled	Pg	
W83	adherent	to	the	beaKng	heat	Kssues	of	zebraﬁsh	larvae.	kdrl:memRFP	
transgenic	zebraﬁsh	larvae	were	infected	with	5	x	104	CFU	ﬂuorescein-labelled	
Pg	W83	at	30	hpf.	Small	green	dots	represent	Pg	W83.	Red	=	zebraﬁsh	
endothelium.		
	
